Gold Gains 1%; ISM Services PMI Surges In May
U.S. stocks traded higher midway through trading, with the Nasdaq Composite surging over 1% on Wednesday. The Dow…
CrowdStrike Outperforms Peers Against Tough Macro In Q1, 10 Analysts Comment On ‘Top Name To Own In Security’
"We continue to be encouraged by the strength in [CrowdStrike's] underlying business," Truist Securities noted.
Why XTI Aerospace Stock Is Flying
XTI Aerospace shares are volatile Wednesday after the company announced Mesa Air Group is the purchaser under a previously disclosed conditional purchase order with XTI Aircraft Company. Here's the details:
What’s Going On With Riot Platforms Stock Wednesday?
Kerrisdale Capital's Sahm Adrangi issued a bearish report on RIOT, criticizing its business model and excessive management compensation. Shares down 16% in past year.
NEAR Protocol Rises More Than 4% In 24 hours
Over the past 24 hours, NEAR Protocol's (CRYPTO: NEAR) price has risen 4.12% to $7.57. This is contrary to its negative trend over the past week where it has experienced a 1.0% loss, moving from $7.61 to its current price.
SEC Chair Gary Gensler Fields Questions On AI, ‘Roaring Kitty’ And Congressional Trading: ‘Disclosure Doesn’t Necessarily Protect A Bad Actor’
Gary Gensler talks AI's role in public markets, recent trading activity in GameStop Corp and insider trading rules in Wednesday CNBC interview.
Shiba Inu’s Price Increased More Than 6% Within 24 hours
Over the past 24 hours, Shiba Inu's (CRYPTO: SHIB) price has risen 6.86% to $0.000026. This is contrary to its negative trend over the past week where it has experienced a 6.0% loss, moving from $0.000027 to its current price.
Solana Rises More Than 4% In 24 hours
Over the past 24 hours, Solana's (CRYPTO: SOL) price has risen 4.11% to $172.88. This continues its positive trend over the past week where it has experienced a 2.0% gain, moving from $168.95 to its current price. As it stands right now, the coin's all-time high is $259.96.
What’s Going On With MindMed And Psychedelic Stocks?
Mind Medicine (MindMed) shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approval of MDMA therapy for people with post-traumatic stress disorder (PTSD). Here's a look at what's moving psychedlic stocks:
Atea Pharmaceuticals Shares Promising Data From Therapy Study For Hepatitis C Virus
Atea Pharmaceuticals announces 97% SVR12 in Phase 2 HCV study of bemnifosbuvir. Data shows high efficacy, safety, and low resistance risk.